Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 271 to 285 of 570 results for pregnancy

  1. Rimegepant for treating migraine (TA919)

    Evidence-based recommendations on rimegepant (Vydura) for the acute treatment of migraine in adults.

    Technology appraisal guidance
    Published
    18 October 2023
    View recommendations

    Sections for TA919

  2. Multiple pregnancy: antenatal care for twin and triplet pregnancies (CG129)

    This guideline has been updated and replaced by NICE guideline NG137

    Withdrawn guideline

  3. Flu vaccination: increasing uptake (QS190)

    This quality standard covers increasing the uptake of flu vaccination among people who are eligible. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    9 January 2020
    View quality statements

    Sections for QS190

  4. Should women having a surgical abortion up to and including 10 +0  weeks' gestation have anti-D prophylaxis if they are RhD (or D) negative?

    outweigh any benefit prophylaxis provides. The NICE guideline on ectopic pregnancy and miscarriage recommends against anti-D prophylaxis...

    Research recommendation
    Published
    8 November 2019

  5. Hospitalisation of pregnant women with unexplained vaginal bleeding: What is the clinical and cost effectiveness of hospitalisation compared with outpatient management for pregnant women with unexplained vaginal bleeding?

    are in evidence review V: management of unexplained vaginal bleeding in pregnancy. Source guidance details Comes from guidance Antenatal

    Research recommendation
    Published
    30 September 2021

  6. Hypertension in pregnancy: diagnosis and management (CG107)

    This guidance has been updated and replaced by NICE guideline NG133

    Withdrawn guideline

  7. Monitoring antiseizure medications in women and girls: What is the clinical and cost effectiveness of therapeutic drug monitoring in girls, young women and women with epilepsy?

    see the rationale section on support and monitoring for women planning pregnancy or who are pregnant. Full details of the evidence and...

    Research recommendation
    Published
    11 May 2022

  8. Membrane sweeping: What are the effectiveness and acceptability of, and maternal satisfaction with, the following: - multiple versus once-only membrane sweeping, at varying gestational ages, depending on parity - membrane sweeping versus cervical massage?

    intervention that may positively influence the transition from maintenance of pregnancy to the onset of labour, reducing the need for...

    Research recommendation
    Published
    15 December 2021

  9. How can fetuses at risk of intrauterine death be identified in women with diabetes?

    Source guidance details Comes from guidance Diabetes in pregnancy: management from preconception to the postnatal period Number

    Research recommendation
    Published
    9 June 2015

  10. Eating disorders: recognition and treatment (NG69)

    This guideline covers assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.

    NICE guideline
    Last updated
    16 December 2020
    View recommendations

    Sections for NG69

  11. Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215)

    This guideline covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants in primary and secondary care.

    NICE guideline
    Published
    20 April 2022
    View recommendations

    Sections for NG215

  12. Spesolimab for treating generalised pustular psoriasis flares (TA1070)

    Evidence-based recommendations on spesolimab (Spevigo) for treating generalised pustular psoriasis flares in adults.

    Technology appraisal guidance
    Published
    18 June 2025
    View recommendations

    Sections for TA1070

  13. Long-term risk of renal scarring and impaired renal function: A well designed cohort study investigating long-term outcomes including renal scarring and renal function of children who have had UTI should be conducted in the UK.

    been associated with severe hypertension, proteinuria, complications in pregnancy and progression to established renal failure. These...

    Research recommendation
    Published
    4 August 2022

  14. Magnesium sulfate for neuroprotection: bolus plus infusion compared with bolus alone:- What is the clinical effectiveness of a bolus plus infusion of magnesium sulfate compared with a bolus alone for preventing neurodevelopmental injury in babies born preterm?

    baby when given to women who will deliver preterm up to 34+0 weeks of pregnancy. However, there is uncertainty about the best method of...

    Research recommendation
    Published
    11 December 2015

  15. Smoking: stopping in pregnancy and after childbirth (PH26)

    This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).

    Withdrawn guideline